简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-07-14 15:40 Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
2025-07-14 13:54 SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
2025-07-14 11:05 iFIT Partners with Samsung Health to Bring Personalized Fitness and Wellness to Millions Across the Globe
2025-07-11 16:55 Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research
2025-07-11 10:08 Newly Elected Directors of Sinovac Hold the First Board Meeting
2025-07-10 16:06 SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment
2025-07-10 16:03 SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
2025-07-10 15:56 Kaneka Obtains Halal Certificate for KANEKA UBIQUINOL TM
2025-07-10 13:01 Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
2025-07-09 19:13 SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares
2025-07-09 19:01 Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote
2025-07-09 10:14 Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella
2025-07-09 10:11 Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial
2025-07-09 09:44 Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD
2025-07-08 18:32 Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC
2025-07-08 13:04 Lubrizol’s Apinovex™ Polymer Wins CPhI China’s 2025 Pharma Excipient Award
2025-07-08 12:57 CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
2025-07-07 11:31 Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place
2025-07-07 11:21 Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place
2025-07-04 10:50 Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year